Demethylzeylasteral suppresses the expression of MESP1 by reducing H3K18la level to inhibit the malignant behaviors of pancreatic cancer
Abstract Glycolysis is a hallmark metabolic pathway in pancreatic cancer (PC). As the end product of glycolysis, lactic acid accumulates significantly in PC. Lactic acid serves as a primary substrate for histone lactylation, leading to an upregulation of histone lactylation levels, which likely cont...
Saved in:
| Main Authors: | Xiaolei Ma, Mengxing Cheng, Yanxin Jia, Kun Zhang, Haocheng Zhang, Di Feng, Wenxiao Xu, Guofen Qiao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-07-01
|
| Series: | Cell Death Discovery |
| Online Access: | https://doi.org/10.1038/s41420-025-02603-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Demethylzeylasteral inhibits proliferation and metastasis of osteosarcoma cells by modulating the PI3K/AKT/Autophagy pathways
by: Xuhui Yuan, et al.
Published: (2025-08-01) -
JAK activity regulates mesoderm cell fate by controlling MESP1 expression
by: Su Yao, et al.
Published: (2024-12-01) -
WCN24-2086 Demethylzeylasteral serum concentration was proved as Tripterygium Glycosides effects Biomarker on diabetic nephropathy treatment
by: MAO YONGHUI, et al.
Published: (2024-04-01) -
Suppression of multiple mouse models of refractory malignancies by reprogramming IL-18 ligand-receptor interaction
by: Zhen Fan, et al.
Published: (2025-07-01) -
HNF4α inhibits the malignancy of intrahepatic cholangiocarcinoma by suppressing the Wnt signaling pathway
by: Bo-Nan Xu, et al.
Published: (2025-03-01)